Recce Pharmaceuticals Ltd
ASX:RCE.AX
0.515 (AUD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q3 | 2015 Q2 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 2.381 | 4.365 | 0 | 3.085 | 0 | 0.997 | 0.64 | 0.05 | 1.072 | 0 | 0.68 | 0.862 | 0.427 | 0.139 | 0 | 0.04 | 0.137 | 0.114 | 0 | 0 |
Cost of Revenue
| 0.173 | 0.193 | 0.142 | 0.075 | 0.079 | 0.108 | 0.205 | 0.091 | 0.1 | 0.1 | 0.029 | 0.366 | 0.238 | 0.214 | 0.703 | 0.368 | 0.176 | 0.057 | 0.028 | 0 | 0.083 |
Gross Profit
| -0.173 | 2.188 | 4.223 | -0.075 | 3.006 | -0.108 | 0.792 | 0.549 | -0.05 | 0.971 | -0.029 | 0.313 | 0.623 | 0.212 | -0.564 | -0.368 | -0.136 | 0.08 | 0.086 | 0 | -0.083 |
Gross Profit Ratio
| 0 | 0.919 | 0.967 | 0 | 0.974 | 0 | 0.794 | 0.858 | -1.008 | 0.906 | 0 | 0.461 | 0.723 | 0.498 | -4.049 | 0 | -3.408 | 0.585 | 0.755 | 0 | -3,961.667 |
Reseach & Development Expenses
| 0 | 4.723 | 3.085 | 4.082 | 3.806 | 2.418 | 1.68 | 3.877 | 1.259 | 0.726 | 0.093 | 0.323 | 0.178 | 0.194 | 0.642 | 0.357 | 0.142 | 0 | 0.054 | 0 | 0 |
General & Administrative Expenses
| 0 | 1.019 | 0.925 | 0.925 | 0.307 | 0.307 | 0.414 | 0.414 | 0.208 | 0.208 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 8.396 | 1.118 | 8.255 | 0.994 | 4.615 | 0.696 | 10.414 | 0.19 | 2.052 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 12.27 | 9.414 | 7.929 | 9.18 | 9.041 | 4.922 | 4.241 | 10.828 | 2.946 | 2.261 | 1.682 | 0.868 | 0.855 | 0.731 | 0.674 | 0.719 | 3.884 | 0.396 | 0.322 | 0 | 0.087 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 12.27 | 9.414 | 7.929 | 9.18 | 9.041 | 4.922 | 4.241 | 10.828 | 2.946 | 2.261 | 1.682 | 1.342 | 1.276 | 1.244 | 1.144 | 1 | 0.743 | 4.032 | 0.351 | 0 | 0.102 |
Operating Income
| -12.444 | -9.608 | -8.07 | -9.255 | -9.12 | -5.03 | -4.446 | -10.918 | -3.047 | -2.361 | -1.711 | -1.029 | -0.601 | -1.031 | -1.677 | -1.368 | -4.212 | -0.433 | -0.265 | 0 | -0.185 |
Operating Income Ratio
| 0 | -4.034 | -1.849 | 0 | -2.956 | 0 | -4.458 | -17.059 | -60.932 | -2.203 | 0 | -1.513 | -0.697 | -2.415 | -12.041 | 0 | -105.378 | -3.158 | -2.328 | 0 | -8,803.238 |
Total Other Income Expenses Net
| -0.381 | -0.135 | -0.096 | 0.033 | 0.032 | 0.047 | 0.199 | 0.086 | 0.062 | -0.042 | -0.013 | -0.037 | -0.029 | -0.013 | -0.016 | 0.035 | 3.327 | -3.523 | -0 | 0 | -0 |
Income Before Tax
| -12.825 | -9.743 | -8.166 | -9.223 | -9.088 | -4.984 | -4.247 | -10.832 | -2.985 | -2.404 | -1.724 | -1.065 | -0.63 | -1.044 | -1.693 | -1.333 | -0.884 | -3.956 | -0.265 | 0 | -0.185 |
Income Before Tax Ratio
| 0 | -4.091 | -1.871 | 0 | -2.946 | 0 | -4.259 | -16.924 | -59.699 | -2.243 | 0 | -1.567 | -0.731 | -2.446 | -12.154 | 0 | -22.121 | -28.866 | -2.329 | 0 | -8,811.333 |
Income Tax Expense
| -2.625 | -2.281 | -4.311 | 0 | -3.085 | -0 | -0.926 | -0.64 | -0 | -1.072 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Income
| -10.2 | -7.462 | -3.855 | -9.223 | -6.003 | -4.984 | -3.321 | -10.192 | -2.985 | -1.332 | -1.724 | -1.065 | -0.63 | -1.044 | -1.693 | -1.333 | -0.884 | -3.956 | -0.265 | 0 | -0.185 |
Net Income Ratio
| 0 | -3.133 | -0.883 | 0 | -1.946 | 0 | -3.33 | -15.924 | -59.699 | -1.243 | 0 | -1.567 | -0.731 | -2.446 | -12.154 | 0 | -22.121 | -28.866 | -2.329 | 0 | -8,811.333 |
EPS
| -0.05 | -0.042 | -0.021 | -0.052 | -0.034 | -0.037 | -0.019 | -0.076 | -0.022 | -0.011 | -0.017 | -0.012 | -0.007 | -0.013 | -0.022 | -0.018 | -0.012 | -0.096 | -0.006 | 0 | -0.009 |
EPS Diluted
| -0.05 | -0.042 | -0.021 | -0.052 | -0.034 | -0.037 | -0.019 | -0.076 | -0.022 | -0.011 | -0.017 | -0.012 | -0.007 | -0.013 | -0.022 | -0.018 | -0.012 | -0.096 | -0.006 | 0 | -0.009 |
EBITDA
| -12.27 | -9.414 | -7.929 | -9.18 | -9.041 | -4.922 | -4.241 | -10.828 | -2.946 | -2.261 | -1.682 | -1.002 | -0.573 | -1.006 | -1.663 | -1.357 | -4.201 | -0.427 | -0.26 | 0 | -0.18 |
EBITDA Ratio
| 0 | -3.953 | -1.816 | 0 | -2.931 | 0 | -4.253 | -16.917 | -58.923 | -2.11 | 0 | -1.474 | -0.665 | -2.355 | -11.937 | 0 | -105.121 | -3.114 | -2.286 | 0 | -8,582.81 |